Northwest Health Prop Real Est Inv Trust…

Home

Daily Stock Opinions and Ratings

Northwest Health Prop Real Est Inv Trust (NWH.UN.TO)

5.66

-0.01 (0.18%)

as of Mar 10, 2026, 8:00:00 pm Market Open.

340 watching

Investor Insights

Aug 23, 2026, 12:00 am

This summary was created by AI, based on 9 opinions in the last 12 months.

Northwest Health Prop Real Est Inv Trust (NWH.UN-T) is undergoing a significant transformation under new management, particularly after the replacement of its former CEO who had expanded into international markets. Analysts highlight the company's focus on streamlining operations, selling off non-core assets, and enhancing its presence in North America, particularly in the growing healthcare sector. The firm is viewed as a turnaround story, with potential for increased value realization as they pay down existing debt and concentrate on long-term leases. While the yields remain attractive at around 6-7%, some experts suggest caution, recommending waiting for potential price dips before making investments. There are hints of takeover rumors, potentially adding to future upside.

Consensus

Cautious

Valuation

Fair Value

Similar

OHI

PAST TOP PICK

(Top Pick Sep 14/12, Down 13.18%) Interest rates went up and people bailed out of these names because people said you should. Can’t believe there has not been a take-over offer on this name.

HOLD

(Market Call Minute.) Largest medical office building owner in Canada. Thinks there is a very good argument to be made for consolidation of the industry. Patient care is going to increase.

BUY

Didn’t participate in the IPO but continues to follow this very closely. Management has done a very good job in trying to tackle the hurdles that it would take for him to invest in this. Hasn’t been many buying opportunities as it has continually traded above NAV, but today it is trading below NAV. Payout ratio is in the 90s so yield should be stable. Occupancy is sitting around 91% and management is trying to get it up to 94% but he is not confident they can. If you Buy today, you are getting a stable yield and at well below what the assets are worth.

BUY ON WEAKNESS

He was lightening up but would be adding at $10.50-$11.

HOLD

Niche company. Build medical office buildings. Grown through accuisition. Need to move non-medical tenants out so they can charge more for medical tenants. Longer term things they will get a dividend bump, but need to be a bit patient and wait twelve months.

DON'T BUY

Has all the qualities that he likes in a REIT. They don’t have to compete to acquire the types of properties they are getting. He didn’t like the valuations on the IPO and has never had a chance to get into the name. Not cheap. Occupancy still hasn’t come back to where they said it would be during the IPO.

BUY

(Market Call Minute.) Medical office buildings. Sees good potential and you get a very attractive dividend yield.

TOP PICK

They are looking to consolidate the medical office buildings in Canada. Growing quite quickly. One of the cheaper REITs in the market. Hoping for a distribution increase.

BUY ON WEAKNESS

The only pure play that owns medical office buildings in Canada. Good management. He would like to buy it at around $12 to get his 15% all-in return.

PAST TOP PICK

(A Top Pick Dec 7/10. Up 9.65%.) Great company and focuses on medical facilities. Still thinks there is upside. REITs are trading at all-time highs. What is keeping them up is the spread between 10 year Canada bonds and the cap rates.

BUY ON WEAKNESS

Has had a wonderful correction and is in an interesting area, one that he has never trusted totally because they've had some vacancy problems. Wouldn't buy at this level but would watch for another opportunity.

COMMENT

Medical office buildings. Outstanding management and quite acquisitive. Has been some pressure on their unit price recently because of some overhang from expectation that they are going to do an equity issue but management has stated there is nothing imminent in this regard. They were overpaying but will cover the distribution next year.

PAST TOP PICK

(A Top Pick Dec 7/10. Up 4.7%.)

BUY

Probably worth $12-$12.50. 12% total return. Management has done a better job than he expected and will consider owning this one.

COMMENT

Hasn’t owned this one but is looking to meet with management. Has done pretty well since its IPO. Would like to own it in the low $11’s or high $10’s at the most.

Showing 106 to 120 of 133 entries

Most Recent Experts

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Darren Sissons

Campbell Lee & Ross

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Northwest Health Prop Real Est Inv Trust (NWH.UN.TO)